Portal de Periódicos da CAPES

Development and Validation of a Scoring System for Predicting Periprocedural Complications During Percutaneous Coronary Interventions of Chronic Total Occlusions: The Prospective Global Registry for the Study of Chronic Total Occlusion Intervention (PROGRESS CTO) Complications Score

2016; Wiley; Volume: 5; Issue: 10 Linguagem: Inglês

10.1161/jaha.116.004272

2047-9980

Barbara A. Danek, Aris Karatasakis, Dimitri Karmpaliotis, Khaldoon Alaswad, Robert W. Yeh, Farouc A. Jaffer, Mitul Patel, Ehtisham Mahmud, William Lombardi, Michael R. Wyman, J. Aaron Grantham, Anthony Doing, David E. Kandzari, Nicholas Lembo, Santiago García, Catalin Toma, Jeffrey W. Moses, Ajay J. Kirtane, Manish A. Parikh, Ziad A. Ali, Judit Karácsonyi, Bavana V. Rangan, Craig A. Thompson, Subhash Banerjee, Emmanouil S. Brilakis,

Acute Myocardial Infarction Research

Background High success rates are achievable for chronic total occlusion ( CTO ) percutaneous coronary intervention ( PCI ) using the hybrid approach, but periprocedural complications remain of concern. Although scores estimating success and efficiency in CTO PCI have been developed, there is currently no available score for estimation of the risk for periprocedural complications. We sought to develop a scoring tool for prediction of periprocedural complications during CTO PCI . Methods and Results We analyzed data from 1569 CTO PCI s in the Prospective Global Registry for the Study of Chronic Total Occlusion Intervention ( PROGRESS CTO ) using a derivation and validation sampling ratio of 2:1. Variables independently associated with periprocedural complications in multivariable analysis in the derivation set were assigned points based on their respective odds ratios. Forty‐four (2.8%) patients experienced complications. Three factors were independent predictors of complications and were included in the score: patient age >65 years, +3 points (odds ratio, OR =4.85, CI 1.82‐16.77); lesion length ≥23 mm, +2 points ( OR =3.22, CI 1.08‐13.89); and use of the retrograde approach +1 point ( OR =2.41, CI 1.04‐6.05). The resulting score showed good calibration and discriminatory capacity in the derivation (Hosmer‐Lemeshow χ 2 6.271, P =0.281, receiver‐operating characteristic [ ROC ] area=0.758) and validation (Hosmer‐Lemeshow χ 2 4.551, P =0.473, ROC area=0.793) sets. Score values of 0 to 2, 3 to 4, and ≥5 were defined as low, intermediate, and high risk of complications (derivation cohort 0.4%, 1.8%, 6.5%, P <0.001; validation cohort 0.0%, 2.5%, 6.8%, P <0.001). Conclusions The PROGRESS CTO complication score is a useful tool for prediction of periprocedural complications in CTO PCI . Clinical Trial Registration URL : http://www.clinicaltrials.gov . Unique identifier: NCT 02061436.